MedPath

国药集团新疆制药有限公司

Ownership
-
Established
1984-08-01
Employees
-
Market Cap
-
Website
http://www.gyxjzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

295

NMPA:295

Drug Approvals

维C银翘片

Approval Number
国药准字Z65020164
Approval Date
Nov 16, 2022
NMPA

维C银翘片

Approval Number
国药准字Z65020110
Approval Date
Jul 22, 2022
NMPA

小儿止咳糖浆

Approval Number
国药准字Z65020159
Approval Date
Feb 11, 2022
NMPA

Compound Guaiacol Potassium Sulfonale Oral Solution

Product Name
复方愈创木酚磺酸钾口服溶液
Approval Number
国药准字H65020222
Approval Date
Feb 11, 2022
NMPA

板蓝根颗粒

Approval Number
国药准字Z65020146
Approval Date
Feb 11, 2022
NMPA

Oral Rehydration Salts Powder(Ⅰ)

Product Name
口服补液盐散(Ⅰ)
Approval Number
国药准字H65020301
Approval Date
Feb 11, 2022
NMPA

清热解毒口服液

Approval Number
国药准字Z65020158
Approval Date
Feb 11, 2022
NMPA

Kendir Extracturm

Product Name
罗布麻浸膏
Approval Number
国药准字H65020248
Approval Date
Jan 7, 2021
NMPA

Pediatric Paracetamol, Atificial Cow-bezoar and Chlorphenamine Maleate Tablets

Product Name
小儿氨酚黄那敏片
Approval Number
国药准字H65020232
Approval Date
Dec 26, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H65020292
Approval Date
Dec 9, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 30
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.